BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 35577752)

  • 1. Epigenetic Aberrations and Targets in Peripheral T-Cell Lymphoma.
    Atallah-Yunes SA; Robertson MJ; Davé UP
    Clin Lymphoma Myeloma Leuk; 2022 Sep; 22(9):659-665. PubMed ID: 35577752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic alterations and advancement of treatment in peripheral T-cell lymphoma.
    Zhang P; Zhang M
    Clin Epigenetics; 2020 Nov; 12(1):169. PubMed ID: 33160401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TET-2 mutations predict poor outcomes and are associated with unfavorable clinical-biological features in PTCL, not otherwise specified and angioimmunoblastic T-cell lymphoma in Brazilian patients.
    de Pádua Covas Lage LA; Barreto GC; Culler HF; Cavalcante JB; de Oliveira Alves LB; Nardinelli L; Bendit I; Zerbini MCN; Rocha V; Pereira J
    Cancer Biomark; 2022; 35(2):179-191. PubMed ID: 36093687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary cutaneous peripheral T-cell lymphomas with a T-follicular helper phenotype: an integrative clinical, pathological and molecular case series study.
    Wang L; Rocas D; Dalle S; Sako N; Pelletier L; Martin N; Dupuy A; Tazi N; Balme B; Vergier B; Beylot-Barry M; Carlotti A; Bagot M; Battistella M; Chaby G; Ingen-Housz-Oro S; Gaulard P; Ortonne N
    Br J Dermatol; 2022 Dec; 187(6):970-980. PubMed ID: 35895386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BCL6 locus is hypermethylated in angioimmunoblastic T-cell lymphoma.
    Nishizawa S; Sakata-Yanagimoto M; Hattori K; Muto H; Nguyen T; Izutsu K; Yoshida K; Ogawa S; Nakamura N; Chiba S
    Int J Hematol; 2017 Apr; 105(4):465-469. PubMed ID: 27921272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New directions in treating peripheral T-cell lymphomas (PTCL): leveraging epigenetic modifiers alone and in combination.
    Ma H; O'Connor OA; Marchi E
    Expert Rev Hematol; 2019 Mar; 12(3):137-146. PubMed ID: 30782038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hematopoietic Cell Transplantation and Adoptive Cell Therapy in Peripheral T Cell Lymphoma.
    Rogers AM; Brammer JE
    Curr Hematol Malig Rep; 2020 Aug; 15(4):316-332. PubMed ID: 32529515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral T-cell lymphomas in a large US multicenter cohort: prognostication in the modern era including impact of frontline therapy.
    Abramson JS; Feldman T; Kroll-Desrosiers AR; Muffly LS; Winer E; Flowers CR; Lansigan F; Nabhan C; Nastoupil LJ; Nath R; Goy A; Castillo JJ; Jagadeesh D; Woda B; Rosen ST; Smith SM; Evens AM
    Ann Oncol; 2014 Nov; 25(11):2211-2217. PubMed ID: 25193992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular pathogenesis of peripheral T-cell lymphoma (1): angioimmunoblastic T-cell lymphoma, peripheral T-cell lymphoma, not otherwise specified and anaplastic large cell lymphoma].
    Couronné L; Bastard C; Gaulard P; Hermine O; Bernard O
    Med Sci (Paris); 2015 Oct; 31(10):841-52. PubMed ID: 26481023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pathological features of angioimmunoblastic T-cell lymphomas with IDH2
    Steinhilber J; Mederake M; Bonzheim I; Serinsöz-Linke E; Müller I; Fallier-Becker P; Lemonnier F; Gaulard P; Fend F; Quintanilla-Martinez L
    Mod Pathol; 2019 Jul; 32(8):1123-1134. PubMed ID: 30952970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The aggressive peripheral T-cell lymphomas: 2015.
    Armitage JO
    Am J Hematol; 2015 Jul; 90(7):665-73. PubMed ID: 26031230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of autologous stem cell transplantation in patients with nodal peripheral T-cell lymphomas in first complete remission: Report from COMPLETE, a prospective, multicenter cohort study.
    Park SI; Horwitz SM; Foss FM; Pinter-Brown LC; Carson KR; Rosen ST; Pro B; Hsi ED; Federico M; Gisselbrecht C; Schwartz M; Bellm LA; Acosta M; Advani RH; Feldman T; Lechowicz MJ; Smith SM; Lansigan F; Tulpule A; Craig MD; Greer JP; Kahl BS; Leach JW; Morganstein N; Casulo C; Shustov AR;
    Cancer; 2019 May; 125(9):1507-1517. PubMed ID: 30694529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigational drugs for T-cell lymphoma.
    Ghez D; Danu A; Ribrag V
    Expert Opin Investig Drugs; 2016; 25(2):171-81. PubMed ID: 26576861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathobiology and molecular profiling of peripheral T-cell lymphomas.
    de Leval L; Gaulard P
    Hematology Am Soc Hematol Educ Program; 2008; ():272-9. PubMed ID: 19074096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angioimmunoblastic T-cell lymphoma contains multiple clonal T-cell populations derived from a common TET2 mutant progenitor cell.
    Yao WQ; Wu F; Zhang W; Chuang SS; Thompson JS; Chen Z; Zhang SW; Clipson A; Wang M; Liu H; Bibawi H; Huang Y; Campos L; Grant JW; Wright P; Ei-Daly H; Rásó-Barnett L; Farkas L; Follows GA; Gao Z; Attygalle AD; Ashton-Key M; Liu W; Du MQ
    J Pathol; 2020 Mar; 250(3):346-357. PubMed ID: 31859368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological Study of 30 Cases of Peripheral T-cell Lymphoma with Hodgkin and Reed-Sternberg-like B-cells from Japan.
    Eladl AE; Satou A; Elsayed AA; Suzuki Y; Kato S; Asano N; Nakamura S
    Am J Surg Pathol; 2017 Apr; 41(4):506-516. PubMed ID: 28125450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma.
    Heavican TB; Bouska A; Yu J; Lone W; Amador C; Gong Q; Zhang W; Li Y; Dave BJ; Nairismägi ML; Greiner TC; Vose J; Weisenburger DD; Lachel C; Wang C; Fu K; Stevens JM; Lim ST; Ong CK; Gascoyne RD; Missiaglia E; Lemonnier F; Haioun C; Hartmann S; Pedersen MB; Laginestra MA; Wilcox RA; Teh BT; Yoshida N; Ohshima K; Seto M; Rosenwald A; Ott G; Campo E; Rimsza LM; Jaffe ES; Braziel RM; d'Amore F; Inghirami G; Bertoni F; de Leval L; Gaulard P; Staudt LM; McKeithan TW; Pileri S; Chan WC; Iqbal J
    Blood; 2019 Apr; 133(15):1664-1676. PubMed ID: 30782609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive analysis of clinical, pathological, and genomic characteristics of follicular helper T-cell derived lymphomas.
    Yoon SE; Cho J; Kim YJ; Ko YH; Park WY; Kim SJ; Kim WS
    Exp Hematol Oncol; 2021 May; 10(1):33. PubMed ID: 33990228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD30 Expression by B and T Cells: A Frequent Finding in Angioimmunoblastic T-Cell Lymphoma and Peripheral T-Cell Lymphoma-Not Otherwise Specified.
    Onaindia A; Martínez N; Montes-Moreno S; Almaraz C; Rodríguez-Pinilla SM; Cereceda L; Revert JB; Ortega C; Tardio A; González L; García S; Camacho FI; González-Vela C; Piris MA
    Am J Surg Pathol; 2016 Mar; 40(3):378-85. PubMed ID: 26574847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic Landscape and Classification of Peripheral T Cell Lymphomas.
    Sandell RF; Boddicker RL; Feldman AL
    Curr Oncol Rep; 2017 Apr; 19(4):28. PubMed ID: 28303495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.